22-04-2025
What are peptides and could they be the missing piece in your longevity regime?
There are now more than 80 therapeutic peptides which have reached the global market to date, according to a paper in Nature journal. It's big business. The global peptide therapeutics market size is calculated at $52.59 billion in 2025 and forecasted to reach around $83.75 billion by 2034 according to Precedence Research. The newest rockstars of the peptide world are ones likes ipamorelin and CJC, which Dr Enayat says he prescribes 'for upregulating growth hormone production', TA-1, for anti-inflammatory purposes, cerebrolysin 'for prevention of common brain related conditions, such as Parkinson's and Alzheimer's disease progression' and BPC-157, the most commonly used peptide for soft tissue injury prevention for people that use their musculoskeletal system a lot' and TB-500, also known as thymosin beta four, 'for soft tissue repair, musculoskeletal injury prevention, and for lean body optimisation.' He says that he does use GLP-1s in clinic for weight loss, Mounjaro in particular, but doesn't like to use them as a first port of call. 'There are often other levers we can pull.'
